These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 30626205

  • 41. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
    Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T.
    J Am Heart Assoc; 2017 Apr 14; 6(4):. PubMed ID: 28411243
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Fibroblast growth factor 21 plays an inhibitory role in vascular calcification in vitro through OPG/RANKL system.
    Cao F, Liu X, Cao X, Wang S, Fu K, Zhao Y, Shen F, Liu J.
    Biochem Biophys Res Commun; 2017 Sep 23; 491(3):578-586. PubMed ID: 28774557
    [Abstract] [Full Text] [Related]

  • 44. ERK1/2 inhibition reduces vascular calcification by activating miR-126-3p-DKK1/LRP6 pathway.
    Zeng P, Yang J, Liu L, Yang X, Yao Z, Ma C, Zhu H, Su J, Zhao Q, Feng K, Yang S, Zhu Y, Li X, Wang W, Duan Y, Han J, Chen Y.
    Theranostics; 2021 Sep 23; 11(3):1129-1146. PubMed ID: 33391525
    [Abstract] [Full Text] [Related]

  • 45. Estrogen inhibits vascular calcification via vascular RANKL system: common mechanism of osteoporosis and vascular calcification.
    Osako MK, Nakagami H, Koibuchi N, Shimizu H, Nakagami F, Koriyama H, Shimamura M, Miyake T, Rakugi H, Morishita R.
    Circ Res; 2010 Aug 20; 107(4):466-75. PubMed ID: 20595654
    [Abstract] [Full Text] [Related]

  • 46. Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB.
    Voelkl J, Tuffaha R, Luong TTD, Zickler D, Masyout J, Feger M, Verheyen N, Blaschke F, Kuro-O M, Tomaschitz A, Pilz S, Pasch A, Eckardt KU, Scherberich JE, Lang F, Pieske B, Alesutan I.
    J Am Soc Nephrol; 2018 Jun 20; 29(6):1636-1648. PubMed ID: 29654213
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix Remodeling.
    Schwanekamp JA, Lorts A, Vagnozzi RJ, Vanhoutte D, Molkentin JD.
    Arterioscler Thromb Vasc Biol; 2016 Jan 20; 36(1):60-8. PubMed ID: 26564821
    [Abstract] [Full Text] [Related]

  • 50. The role of vascular peroxidase 1 in ox-LDL-induced vascular smooth muscle cell calcification.
    Tang Y, Xu Q, Peng H, Liu Z, Yang T, Yu Z, Cheng G, Li X, Zhang G, Shi R.
    Atherosclerosis; 2015 Dec 20; 243(2):357-63. PubMed ID: 26520887
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
    Chen X, Qian S, Hoggatt A, Tang H, Hacker TA, Obukhov AG, Herring PB, Seye CI.
    Arterioscler Thromb Vasc Biol; 2017 Jan 20; 37(1):75-83. PubMed ID: 27856454
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
    Song D, Fang G, Mao SZ, Ye X, Liu G, Miller EJ, Greenberg H, Liu SF.
    Atherosclerosis; 2018 Mar 20; 270():68-75. PubMed ID: 29407890
    [Abstract] [Full Text] [Related]

  • 55. Differential effects of vitamin D analogs on vascular calcification.
    Cardús A, Panizo S, Parisi E, Fernandez E, Valdivielso JM.
    J Bone Miner Res; 2007 Jun 20; 22(6):860-6. PubMed ID: 17352647
    [Abstract] [Full Text] [Related]

  • 56. Relevance of the myeloid differentiation factor 88 (MyD88) on RANKL, OPG, and nod expressions induced by TLR and IL-1R signaling in bone marrow stromal cells.
    Leite FR, de Aquino SG, Guimarães MR, Cirelli JA, Zamboni DS, Silva JS, Junior CR.
    Inflammation; 2015 Feb 20; 38(1):1-8. PubMed ID: 25125146
    [Abstract] [Full Text] [Related]

  • 57. Nitrogen-containing bisphosphonate induces enhancement of OPG expression and inhibition of RANKL expression via inhibition of farnesyl pyrophosphate synthase to inhibit the osteogenic differentiation and calcification in vascular smooth muscle cells.
    Xu W, Gong L, Tang W, Lu G.
    BMC Cardiovasc Disord; 2024 Sep 17; 24(1):494. PubMed ID: 39289624
    [Abstract] [Full Text] [Related]

  • 58. Overexpression of c1q/tumor necrosis factor-related protein-3 promotes phosphate-induced vascular smooth muscle cell calcification both in vivo and in vitro.
    Zhou Y, Wang JY, Feng H, Wang C, Li L, Wu D, Lei H, Li H, Wu LL.
    Arterioscler Thromb Vasc Biol; 2014 May 17; 34(5):1002-10. PubMed ID: 24578384
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. The role of heat shock protein 90 in migration and proliferation of vascular smooth muscle cells in the development of atherosclerosis.
    Kim J, Jang SW, Park E, Oh M, Park S, Ko J.
    J Mol Cell Cardiol; 2014 Jul 17; 72():157-67. PubMed ID: 24650873
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.